RGEN
Repligen Corp
Price:  
155.99 
USD
Volume:  
495,600.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Relative Valuation

-90.5%
Upside

As of 2024-12-13, the Relative Valuation of Repligen Corp (RGEN) is 14.85 USD. This relative valuation is based on P/E multiples. With the latest stock price at 155.99 USD, the upside of Repligen Corp based on Relative Valuation is -90.5%.

The range of the Relative Valuation is (8.00) - 39.12 USD.

Range Selected
Trailing P/E multiples 29.8x - 33.7x 32.7x
Forward P/E multiples 32.2x - 34.2x 33.6x
Fair Price (8.00) - 39.12 14.85
Upside -105.1% - -74.9% -90.5%
155.99 USD
Stock Price
14.85 USD
Fair Price

RGEN Relative Valuation - Historical P/E Data

Date P/E
2024-12-13 -582.73
2024-12-12 -581.16
2024-12-11 -578.41
2024-12-10 -566.07
2024-12-09 -576.43
2024-12-06 -555.87
2024-12-05 -530.01
2024-12-04 -555.46
2024-12-03 -553.26
2024-12-02 -560.56
2024-11-29 -560.86
2024-11-27 -558.81
2024-11-26 -546.70
2024-11-25 -544.17
2024-11-22 -531.20
2024-11-21 -528.15
2024-11-20 -517.49
2024-11-19 -478.71
2024-11-18 -459.78
2024-11-15 -464.70
2024-11-14 -530.64
2024-11-13 -560.60
2024-11-12 -553.59
2024-11-11 -519.76
2024-11-08 -524.20
2024-11-07 -536.05
2024-11-06 -543.68
2024-11-05 -543.76
2024-11-04 -519.84
2024-11-01 -516.41
2024-10-31 -500.24
2024-10-30 -508.10
2024-10-29 -502.48
2024-10-28 -511.20
2024-10-25 -504.64
2024-10-24 -503.63
2024-10-23 -512.20
2024-10-22 -537.01
2024-10-21 -555.90
2024-10-18 -547.48
2024-10-17 -529.56
2024-10-16 -514.77
2024-10-15 -540.14
2024-10-14 -532.95
2024-10-11 -517.19
2024-10-10 -501.06
2024-10-09 -508.74
2024-10-08 -503.04
2024-10-07 -508.89
2024-10-04 -509.33